Self‐microemulsifying drug delivery system‐based gastroretentive in situ raft of pazopanib with enhanced solubility and bioavailability
Archiv der Pharmazie · 2025-01 · 358 (1)
DOI: 10.1002/ardp.202400179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 24.10.2024. Verfasst von Vridhi Sachdeva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, India. Hauptthemen laut MEDLINE: Biological Availability, Solubility, Pyrimidines, Sulfonamides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
Pazopanib hydrochloride (PZH) is a Biopharmaceutics Classification System class II drug that faces challenges at the formulation forefront including low aqueous solubility (0.043 mg/mL) and poor oral bioavailability (14–39%). The present investigation aimed to develop a self‐microemulsifying drug delivery system (SMEDDS) of PZH using a blend of Capryol® 90, Labrasol®, and propylene glycol to improve its solubility. Furthermore, a sustained‐release SMEDDS‐based gastroretentive floating system was developed and optimized using the Central Composite Design approach of DoE. The optimized SMEDDS‐based in situ gelling raft, R‐SM‐PZH, exhibited minimal floating lag time (3.09 ± 0.8 s), optimal viscosity (1229.4 ± 20.9 cP) and density (0.327 ± 0.15 g/mL) as compared to other formulations under study. Additionally, R‐SM‐PZH was evaluated for its in vitro dissolution in FaSSGF and FeSSGF, pharmacokinetic profile, and MTT assay (against NCI‐H460 lung cancer cells) compared to pure PZH. A 12 h sustained release, three‐fold augmentation in dissolution rate and bioavailability, and 15‐fold enhancement in cytotoxicity were observed in comparison to pure PZH. Thus, the SMEDDS‐based in situ gelling raft presents a promising approach to advancing the developability potential of PZH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, India.
- Department of Botanical and Environmental Sciences, Guru Nanak Dev University, Amritsar, India.
ORCID-Profile: Neena Bedi
Förderung
- None
Zitieren
APA
Sachdeva, V., Mehra, A., Singh, G., Kumar, A., Kumar, P., Singh, G., & Bedi, N. (2025). Self‐microemulsifying drug delivery system‐based gastroretentive in situ raft of pazopanib with enhanced solubility and bioavailability. Archiv der Pharmazie, 358(1). https://doi.org/10.1002/ardp.202400179
Vancouver
Sachdeva V, Mehra A, Singh G, Kumar A, Kumar P, Singh G, et al. Self‐microemulsifying drug delivery system‐based gastroretentive in situ raft of pazopanib with enhanced solubility and bioavailability. Archiv der Pharmazie. 2025;358(1). doi:10.1002/ardp.202400179
BibTeX
@article{Sachdeva2025,
author = {Sachdeva, Vridhi and Mehra, Anshula and Singh, Gurdeep and Kumar, Akshay and Kumar, Pranesh and Singh, Gurpreet and Bedi, Neena},
title = {Self‐microemulsifying drug delivery system‐based gastroretentive in situ raft of pazopanib with enhanced solubility and bioavailability},
journal = {Archiv der Pharmazie},
year = {2025},
volume = {358},
number = {1},
doi = {10.1002/ardp.202400179}
}
EUVIMED